NEW YORK (GenomeWeb News) - Acacia Research said yesterday that it has received commitments for the purchase of $5 million in Acacia Research-CombiMatrix common stock and warrants through a direct offering that includes several CombiMatrix executives. 
 
Acacia plans to sell 6.8 million units at $.738 per share to "a select group of investors" including CombiMatrix President and CEO Amit Kumar and company directors Tom Akin and John Abeles.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The ancestors of the Arizona bark scorpion and other scorpions and spiders underwent whole-genome duplication, KJZZ reports.

A cryptographic approach could help researchers keep genomic data private while researchers analyze it, Scientific American reports.

Andy Page, the former president of 23andMe, has joined a diabetes-management startup, according to CNBC.

In Cell this week: regulatory changes in pancreatic cancer, metabolic shifts in Alzheimer's disease, and more.